135 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
) of the grant date fair value due to stock price decline associated with our Phase 2 PENINSULA trial, reinforcing the highly at-risk nature of our
8-K
EX-99.1
xmymjr9sh0l9 q34v4hw
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
S-3ASR
l5nf0ue071qg788n24
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.5
m9lmzm rs7o7u1v1j
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.6
ber4kml715y s5kn1jt
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
zkmdmx
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm